Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Material Contracts, 2012

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2012-12-21: Form 8-K; Exhibit 10.6; Description PROTHENA CORPORATION PLC INCENTIVE COMPENSATION PLAN.
  • 2012-12-21: Form 8-K; Exhibit 10.5; Description PROTHENA BIOSCIENCES INC SEVERANCE PLAN.
  • 2012-12-21: Form 8-K; Exhibit 10.4; Description PROTHENA CORPORATION PLC 2012 LONG TERM INCENTIVE PLAN.
  • 2012-12-21: Form 8-K; Exhibit 10.3; Description RESEARCH AND DEVELOPMENT SERVICES AGREEMENT.
FiledFormExhibitDescription
2012-12-218-K10.6PROTHENA CORPORATION PLC INCENTIVE COMPENSATION PLAN
2012-12-218-K10.5PROTHENA BIOSCIENCES INC SEVERANCE PLAN
2012-12-218-K10.4PROTHENA CORPORATION PLC 2012 LONG TERM INCENTIVE PLAN
2012-12-218-K10.3RESEARCH AND DEVELOPMENT SERVICES AGREEMENT
2012-12-218-K10.2TRANSITIONAL SERVICES AGREEMENT
2012-12-218-K10.1TAX MATTERS AGREEMENT

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10